SCH 503034 Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659)(COMPLETED)

This study has been completed.
Information provided by Schering-Plough

Please refer to this study by its ClinicalTrials.gov identifier: NCT00160251

Sponsors and Collaborators